Physician profile
Ethan Meltzer
NPI 1467865790
$42,364.95
in general payments reported to CMS, 2019-2025
9 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $7,953 · 2021: $46.00 · 2022: $1,899 · 2023: $15K · 2024: $552 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $1,464 · Travel and Lodging: $1,115 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,620.00 |
| Food and Beverage | $1,463.61 |
| Travel and Lodging | $1,115.49 |
| Education | $109.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $13,884.68 | 2019-2024 | |
| Biogen, INC. | $8,290.74 | 2019-2023 | Tysabri, Vumerity |
| Genentech USA, INC. | $7,981.07 | 2023-2024 | Ocrevus, Ocrevus Zunovo |
| Tg Therapeutics, INC. | $5,606.29 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $4,438.61 | 2019-2025 | Kesimpta |
| Horizon Therapeutics Plc | $1,750.00 | 2022 | |
| Emd Serono, INC. | $368.37 | 2021-2024 | |
| Celgene Corporation | $27.73 | 2021 | |
| Abbott Laboratories | $17.46 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Meltzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.